Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines
about
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimenDNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.Nucleic acid vaccines.Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.Simian immunodeficiency virus DNA vaccine trial in macaques.Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccineAIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
P2860
Q33639684-BF3E52C5-E98C-42B6-BBC8-6618617044F1Q33783841-E539C254-DBF9-45D1-AEFB-4164F750B542Q35535126-D91869C8-C07A-42C2-8FDA-BB19D7B288B3Q35848231-FA9AF2DD-813C-4C9D-B738-AD03A6A822E0Q35854001-DD1E7182-3AC3-485C-8C40-BB7E3488BF64Q35854152-B80AB5AB-9536-449B-A468-B0C9DF18F87AQ35857571-E0AA6057-64EF-4969-A983-A8AC10814B5EQ35861490-B83C7988-26A5-412C-AC83-F34EC199765EQ35861970-E91A3543-7847-453B-AC9B-D4DD7CC24717Q35897786-741880A0-F5A0-4151-B9FD-871B6B97D448Q35898304-80F7AC63-4ED3-451F-8C41-CE5EBC7220A3Q36636293-34016A47-640A-4E71-9795-33D470D47AE5Q36924415-3C9CD41E-48DD-499B-B951-92C7723C93BDQ37625485-23226191-4678-4FAE-A33F-EC64B41A2966Q39548535-596C4FAC-005D-4D76-967F-DF8FA8775C31Q39602555-12F600EA-895D-413B-9096-8560FD883407Q39699309-D990DA54-08CA-4296-BB00-AA5D78FE9397Q39874667-83086A3A-FB3C-4BCB-9F30-56656AA90DC3Q40043196-503EEAC6-F63A-4AF9-BE80-C8EF7CBCB36C
P2860
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@ast
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@en
type
label
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@ast
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@en
prefLabel
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@ast
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@en
P2093
P2860
P1433
P1476
Incomplete protection, but sup ...... mmunodeficiency virus vaccines
@en
P2093
C Thiriart
O Van Opstal
P F Edmonson
S P Mossman
S P O'Neil
Z R Israel
P2860
P304
P407
P577
1994-03-01T00:00:00Z